PedAM
Pediatric Disease Annotations & Medicines
| Disease | nephrogenic systemic fibrosis |
| Phenotype | C0035078|renal failure |
| Sentences | 12 |
| PubMedID- 24778878 | However, there is a link between the administration of less stable gadolinium contrast agents (i.e., gadodiamide) and nephrogenic systemic fibrosis (nsf) in patients with severe renal failure (glomerular filtration rate (gfr) < 30 ml/min/cm2) [6–10]. |
| PubMedID- 25075142 | Periarticular amyloid may enhance mildly after gadolinium administration.5, 6 however, the administration of gadolinium has been linked to the development of nephrogenic systemic fibrosis in patients with advanced renal failure, in particular patients on dialysis and is contraindicated in this patient group. |
| PubMedID- 26576944 | After the administration of gd-dtpa, cases of nephrogenic systemic fibrosis (nsf) in patients with renal failure have been reported, leading to a new risk classification of contrast media [6]. |
| PubMedID- 20032228 | Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network. |
| PubMedID- 23976896 | In these patients, magnetic resonance imaging could not be used as an alternate imaging modality as gadolinium-based contrast agents have been implicated in nephrogenic systemic fibrosis when used in patients with renal failure. |
| PubMedID- 22815709 | All these findings indicate that studies are necessary to the prevention of gadolinium-chelate nephrotoxicity and to nephrogenic systemic fibrosis in patients with chronic renal failure [15]. |
| PubMedID- 24608937 | However, since the risk of nephrogenic systemic fibrosis (nsf) in patients with chronic renal failure was reported [5], [6], interest in non-enhanced mr angiography techniques has markedly increased [7]–[9]. |
| PubMedID- 19447204 | From the clinical editor: chelated gadolinium (gd) contrast agents have been linked to a debilitating disease called nephrogenic systemic fibrosis (nsf) in patients with renal failure. |
| PubMedID- 19913804 | In 1997 a new disorder, nephrogenic systemic fibrosis, appeared in patients with severe renal failure. |
| PubMedID- 23354034 | nephrogenic systemic fibrosis in a patient with renal failure demonstrating a "reverse superscan" on bone scintigraphy. |
| PubMedID- 25315722 | nephrogenic systemic fibrosis appears only in patients with renal failure and it has a very severe prognosis due to the systemic organ involvement. |
| PubMedID- 22704222 | Background: late gadolinium enhanced (lge) cardiovascular magnetic resonance (cmr) is frequently used to evaluate myocardial viability, estimate total infarct size and transmurality, but is not always straightforward is and contraindicated in patients with renal failure because of the risk of nephrogenic systemic fibrosis. |
Page: 1